Next Capital Management’s Novo Nordisk NVO Stock Holding History

Next Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-344	Closed	-$9K	–	621
2019 Q2	$9K	Buy	+344	New	+$8.5K	0.01%	467

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Next Capital Management's NVO Position: Q3 2019 in Review

Next Capital Management sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 344 shares — an estimated $9K sold.

Next Capital Management first reported a position in NVO in Q2 2019 and held it in 1 quarter. The position peaked at $9K in Q2 2019. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

Next Capital Management reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
Next Capital Management sold 344 Novo Nordisk shares in Q3 2019, an estimated $9K.
Next Capital Management first reported a position in Novo Nordisk in Q2 2019 and held it in 1 quarter.
Next Capital Management's Novo Nordisk position peaked at $9K in Q2 2019.
564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.